- Country: USA
- Summary: NOI - Abbott Chemistry & Immunoassay Analyzer System - Naval Medical Center Portsmouth, VA
- UST Ref No: 122346229
- Deadline: 24 Jul 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.:
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
The Defense Health Agency (DHA) intends to award a sole source contract under the authority of 41 U.S.C. 1901, to Abbott Laboratories Inc. (Abbott), 100 Abbott Park Road, Abbott Park, Illinois 60064-6095, for the provision to provide all personnel, equipment, supplies, facilities, transportation, tools, materials, supervision, and other items necessary to provide required lease agreement for three (3) Abbott ALINITY ci Analyzers and one (1) ARCHITECT i1000SR immunoassay analyzer, ancillary and automation system upgrades, Cost-Per-Test Agreement, Consumables (reagents) and Maintenance Support Services to Naval Medical Center Portsmouth, VA (NMCP) to annual quantities in Attachment 1 and meeting all requirements in Attachment 2. The period of performance is 01 January 2026 through 31 December 2026 with 4 (four) 12-month option periods.
Generally, NMCP-s requirement is for chemistry/immunoassay analyzers of the same model which can perform the same tests to work together and form a chemistry/immunoassay system capable of performing general chemistry, special chemistry, immunoassay, and screening for electrolytes, therapeutic drugs, drugs of abuse, toxicology, hepatitis, diabetes, hepatic diseases, thyroid diseases, cardiac diseases, anemia panels, and autoimmune diseases. Abbott will provide a lease of four (4) total Abbott Chemistry and Immunochemistry Systems/Units including Three (3) Alinity ci series analyzers, One (1) Architect i1000SR analyzer and subcomponents which comprise of One (1) Desealer module, Two (2) Tube identification modules (TIM), one (1) 15K storage with a storage align module kit, one (1) Slot Non-STAT Divert module, one (1) Preassembled double straight Spur Set, accessory and tool kits and three (3) ALINITY ci Series System Control Modules. The Abbott chemistry/immunoassay analyzer system can perform at least, but not be limited to, the tests and of performing each test at least at the minimum workload identified in the Minim... - Documents:
Attachment-2-Chemistry-Immunoassay-System-Essent.docx
Attachment-1-Minimum-Estimated-Required-Workload.docx
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINNOI - Abbott Chemistry & Immunoassay Analyzer System - Naval Medical Center Portsmouth, VA - USA Tender
The DEPT OF DEFENSE | DEFENSE HEALTH AGENCY (DHA), a Government sector organization in USA, has announced a new tender for NOI - Abbott Chemistry & Immunoassay Analyzer System - Naval Medical Center Portsmouth, VA. This tender is published on USARFP under UST Ref No: 122346229 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-07-24.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
